A jury found Abbott Laboratories and Mead Johnson, owned by U.K.-based Reckitt Benckiser, not responsible for a young boy's intestinal disease, the result of a lawsuit that alleged the companies ...
The decision marks the first victory for the companies as they face more than 1,000 similar cases and previously lost trials, one of which ended with a $500 million verdict.
Shares of Abbott, which makes the Similac formula, rose 5.4% to $ ... in compensation related to the death of a premature baby that was fed its Enfamil Premature 24 product. Nearly 1,000 such ...
Abbott Laboratories and a unit of Reckitt Benckiser Group were cleared by a jury over claims they hid risks in their premature-infant formulas can cause a bowel disease that severely sickened a baby ...